Skip to main content
. 2024 Feb 8;21:13. doi: 10.1186/s12987-024-00519-7

Table 1.

Overview of pharmacology and PN-centered toxicology of the selected drugs

Category Compound Pharmacology Localization of a pharmacological target Toxicology (PN)
Class Pharmacological target Positive or negative Target site
CIPN-positive or negative Paclitaxel Taxane Tubulin Intracellular Positive DRG, axon, and distal nerve termina [48]
Vincristine Vinca alkaloid Tubulin Intracellular Positive DRG, axon [49]
Methotrexate Antimetabolite

Dihydrofolate reductase

Thymidylate synthase

Bifunctional purine biosynthesis protein

Intracellular Negative N.A
Nilotinib Tyrosine kinase inhibitor

Tyrosine-protein kinase ABL-1§

Mast/stem cell growth factor receptor

Intracellular§ Negative N.A
PN-positive or negative Isoniazid Antitubercular agent

Long-chain enoyl-acyl carrier protein reductase (InhA)

Pyridoxal kinasea

Intracellular Positive Nerve terminals [50]
Acrylamide N.A N.A Positive Nerve terminals [51]
Varenicline Smoking cessation aid α4β2 neuronal nicotinic acetylcholine receptor Extracellular Negative N.A
Oxycodone Opioid analgesic Opioid receptors Extracellular Negative N.A
Paroxetine Selective serotonin-reuptake inhibitor Serotonin reuptake transporter Extracellular Negative N.A
Monomethyl fumarate Immunomodulatory drug Nuclear factor erythroid 2-related factor 2 Intracellular Negative N.A
Diazepam Benzodiazepine GABA receptor Extracellular Negative N.A

aToxicological target

§localization is listed only for Tyrosine-protein kinase ABL-1

N.A. not applicable, N.I. not identified